Lipid Nanoparticles (LNP) Industry Research Report 2025

Summary

According to APO Research, The global Lipid Nanoparticles (LNP) market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lipid Nanoparticles (LNP) include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical and Lipoid, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticles (LNP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticles (LNP).

The Lipid Nanoparticles (LNP) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Nanoparticles (LNP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Lipid Nanoparticles (LNP) Segment by Company

Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid

Lipid Nanoparticles (LNP) Segment by Type

mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others

Lipid Nanoparticles (LNP) Segment by Application

Vaccines and Drugs
Scientific Research

Lipid Nanoparticles (LNP) Segment by Application

Vaccines and Drugs
Scientific Research

Lipid Nanoparticles (LNP) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticles (LNP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticles (LNP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticles (LNP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Lipid Nanoparticles (LNP) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Lipid Nanoparticles (LNP) by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 mRNA-lipid Nanoparticle
2.2.3 siRNA-lipid Nanoparticle
2.2.4 Others
2.3 Lipid Nanoparticles (LNP) by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Vaccines and Drugs
2.3.3 Scientific Research
2.4 Assumptions and Limitations
3 Lipid Nanoparticles (LNP) Breakdown Data by Type
3.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Type (2020-2025)
3.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Type (2026-2031)
4 Lipid Nanoparticles (LNP) Breakdown Data by Application
4.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Application (2020-2025)
4.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Lipid Nanoparticles (LNP) Market Perspective (2020-2031)
5.2 Global Lipid Nanoparticles (LNP) Growth Trends by Region
5.2.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Lipid Nanoparticles (LNP) Historic Market Size by Region (2020-2025)
5.2.3 Lipid Nanoparticles (LNP) Forecasted Market Size by Region (2026-2031)
5.3 Lipid Nanoparticles (LNP) Market Dynamics
5.3.1 Lipid Nanoparticles (LNP) Industry Trends
5.3.2 Lipid Nanoparticles (LNP) Market Drivers
5.3.3 Lipid Nanoparticles (LNP) Market Challenges
5.3.4 Lipid Nanoparticles (LNP) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue
6.1.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue (2020-2025)
6.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2020-2025)
6.2 Global Lipid Nanoparticles (LNP) Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Lipid Nanoparticles (LNP) Head Office and Area Served
6.4 Global Lipid Nanoparticles (LNP) Players, Product Type & Application
6.5 Global Lipid Nanoparticles (LNP) Manufacturers Established Date
6.6 Global Lipid Nanoparticles (LNP) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Lipid Nanoparticles (LNP) Market Size (2020-2031)
7.2 North America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Lipid Nanoparticles (LNP) Market Size by Country (2020-2025)
7.4 North America Lipid Nanoparticles (LNP) Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Lipid Nanoparticles (LNP) Market Size (2020-2031)
8.2 Europe Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Lipid Nanoparticles (LNP) Market Size by Country (2020-2025)
8.4 Europe Lipid Nanoparticles (LNP) Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Lipid Nanoparticles (LNP) Market Size (2020-2031)
9.2 Asia-Pacific Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2020-2025)
9.4 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Lipid Nanoparticles (LNP) Market Size (2020-2031)
10.2 South America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Lipid Nanoparticles (LNP) Market Size by Country (2020-2025)
10.4 South America Lipid Nanoparticles (LNP) Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Lipid Nanoparticles (LNP) Market Size (2020-2031)
11.2 Middle East & Africa Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2020-2025)
11.4 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Precision NanoSystems
12.1.1 Precision NanoSystems Company Information
12.1.2 Precision NanoSystems Business Overview
12.1.3 Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.1.4 Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio
12.1.5 Precision NanoSystems Recent Developments
12.2 Evonik
12.2.1 Evonik Company Information
12.2.2 Evonik Business Overview
12.2.3 Evonik Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.2.4 Evonik Lipid Nanoparticles (LNP) Product Portfolio
12.2.5 Evonik Recent Developments
12.3 Merck KGaA
12.3.1 Merck KGaA Company Information
12.3.2 Merck KGaA Business Overview
12.3.3 Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.3.4 Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio
12.3.5 Merck KGaA Recent Developments
12.4 Genevant Sciences
12.4.1 Genevant Sciences Company Information
12.4.2 Genevant Sciences Business Overview
12.4.3 Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.4.4 Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio
12.4.5 Genevant Sciences Recent Developments
12.5 Exelead
12.5.1 Exelead Company Information
12.5.2 Exelead Business Overview
12.5.3 Exelead Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.5.4 Exelead Lipid Nanoparticles (LNP) Product Portfolio
12.5.5 Exelead Recent Developments
12.6 Avanti Polar Lipids
12.6.1 Avanti Polar Lipids Company Information
12.6.2 Avanti Polar Lipids Business Overview
12.6.3 Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.6.4 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio
12.6.5 Avanti Polar Lipids Recent Developments
12.7 Nippon Fine Chemical
12.7.1 Nippon Fine Chemical Company Information
12.7.2 Nippon Fine Chemical Business Overview
12.7.3 Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.7.4 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio
12.7.5 Nippon Fine Chemical Recent Developments
12.8 Lipoid
12.8.1 Lipoid Company Information
12.8.2 Lipoid Business Overview
12.8.3 Lipoid Revenue in Lipid Nanoparticles (LNP) Business (2020-2025)
12.8.4 Lipoid Lipid Nanoparticles (LNP) Product Portfolio
12.8.5 Lipoid Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings